These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quantification of steroid hormones in plasma using a surrogate calibrant approach and UHPLC-ESI-QTOF-MS/MS with SWATH-acquisition combined with untargeted profiling. Drotleff B, Hallschmid M, Lämmerhofer M. Anal Chim Acta; 2018 Aug 31; 1022():70-80. PubMed ID: 29729740 [Abstract] [Full Text] [Related]
3. Lipidomic profiling of non-mineralized dental plaque and biofilm by untargeted UHPLC-QTOF-MS/MS and SWATH acquisition. Drotleff B, Roth SR, Henkel K, Calderón C, Schlotterbeck J, Neukamm MA, Lämmerhofer M. Anal Bioanal Chem; 2020 Apr 31; 412(10):2303-2314. PubMed ID: 31942654 [Abstract] [Full Text] [Related]
4. Untargeted UHPLC-ESI-QTOF-MS/MS analysis with targeted feature extraction at precursor and fragment level for profiling of the platelet lipidome with ex vivo thrombin-activation. Cebo M, Calderón Castro C, Schlotterbeck J, Gawaz M, Chatterjee M, Lämmerhofer M. J Pharm Biomed Anal; 2021 Oct 25; 205():114301. PubMed ID: 34391135 [Abstract] [Full Text] [Related]
6. Evaluation of lipid quantification accuracy using HILIC and RPLC MS on the example of NIST® SRM® 1950 metabolites in human plasma. Lange M, Fedorova M. Anal Bioanal Chem; 2020 Jun 25; 412(15):3573-3584. PubMed ID: 32240327 [Abstract] [Full Text] [Related]
9. Validation of lipidomic analysis of human plasma and serum by supercritical fluid chromatography-mass spectrometry and hydrophilic interaction liquid chromatography-mass spectrometry. Wolrab D, Chocholoušková M, Jirásko R, Peterka O, Holčapek M. Anal Bioanal Chem; 2020 Apr 25; 412(10):2375-2388. PubMed ID: 32078000 [Abstract] [Full Text] [Related]
10. Validation of a multiplexed and targeted lipidomics assay for accurate quantification of lipidomes. Zhang NR, Hatcher NG, Ekroos K, Kedia K, Kandebo M, Marcus JN, Smith SM, Bateman KP, Spellman DS. J Lipid Res; 2022 Jun 25; 63(6):100218. PubMed ID: 35489416 [Abstract] [Full Text] [Related]
11. Plasma lipidomics reveals potential lipid markers of major depressive disorder. Liu X, Li J, Zheng P, Zhao X, Zhou C, Hu C, Hou X, Wang H, Xie P, Xu G. Anal Bioanal Chem; 2016 Sep 25; 408(23):6497-507. PubMed ID: 27457104 [Abstract] [Full Text] [Related]
15. An Untargeted Lipidomics Workflow Incorporating High-Resolution Demultiplexing (HRdm) Drift Tube Ion Mobility-Mass Spectrometry. Koomen DC, May JC, Mansueto AJ, Graham TR, McLean JA. J Am Soc Mass Spectrom; 2024 Oct 02; 35(10):2448-2457. PubMed ID: 39276100 [Abstract] [Full Text] [Related]
16. A Novel Lipidomics Workflow for Improved Human Plasma Identification and Quantification Using RPLC-MSn Methods and Isotope Dilution Strategies. Rampler E, Criscuolo A, Zeller M, El Abiead Y, Schoeny H, Hermann G, Sokol E, Cook K, Peake DA, Delanghe B, Koellensperger G. Anal Chem; 2018 Jun 05; 90(11):6494-6501. PubMed ID: 29708737 [Abstract] [Full Text] [Related]
17. Development and application of a fast ultra-high performance liquid chromatography-trapped ion mobility mass spectrometry method for untargeted lipidomics. Merciai F, Musella S, Sommella E, Bertamino A, D'Ursi AM, Campiglia P. J Chromatogr A; 2022 Jun 21; 1673():463124. PubMed ID: 35567813 [Abstract] [Full Text] [Related]
18. Development of lipidomic platform and phosphatidylcholine retention time index for lipid profiling of rosuvastatin treated human plasma. Choi JM, Kim TE, Cho JY, Lee HJ, Jung BH. J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan 01; 944():157-65. PubMed ID: 24316528 [Abstract] [Full Text] [Related]